Patrick Frost, PhD

Patrick Frost, PhD

Jan 13, 2016

Group 6 Copy 41
-1
    Please wait...

    About This Project

    BBRI and Los Angeles VA Medical Center

    Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Can we predict individual identity, age, and gender of Mexican gray wolves from their scent?

    Wolves play an important role in ecosystem health. When re-introduced into forests like Yellowstone, they helped...

    Pieris Project: using citizen science to learn how species will respond to climate change

    Climate change will dramatically alter the planet’sbiodiversity, yet we know little about how most species will...

    Backer Badge Funded